A Replication-Competent, Conditionally Auto-Inhibiting Vector for Delivery of HIV Cure Genetics

Closed
VectorGen
Albany, New York, United States
LP
Founder
3
Preferred learners
  • Anywhere
  • Academic experience
Categories
Product or service launch
Skills
design thinking business strategy
Project scope
What is the main goal for this project?

From speaking with Orly Weinberg, my understanding is that she is facilitating a course in Synthetic Biology. The students are tasked with designing a Research Strategy for the development of the VectorGen vector. They will set forth the elements of the experimental program to validate its unique genetic mechanism, enabling them to learn about the science underpinning the techniques of Molecular Genetics that will ultimately be used to manufacture the vector in vitro

About the company

VectorGen was originally formed as a funding entity for HIV cure research. Our founder has an impressive array of diverse projects that range from civic ventures to role-playing game-based learning programs.

VectorGen has been working with Riipen for well over five years, developing projects with student groups from the USA, Canada, and Australia.

Recently, VectorGen has partnered with The Visionaries, an independent venture studio for early-stage startups that provides talent, innovation, technology, and funding services with a global perspective to accelerate startup growth, delivering tailored plans and training for success in the competitive startup landscape.